PYRAMECTIN 25 mg for dogs/ HEARTWORM DISEASE/ DIROFILARIA SPP

PHARMACEUTICAL FORM: tablets

TARGET SPECIES: Dogs

INDICATIONS:

The product is recommended in dogs in the treatment of infestations with Dirofilaria immitis, Toxocara canis, Toxascaris leonina, Ancylostoma caninum, Uncinaria stenocephala.

COMPOSITION:

1 tablet contains:

Active substances :
Pyrantel pamoat ........................ 114 mg
Ivermectin...................................... 136 μg
Excipients:
Lactose Monohydrate, Microcrystalline Cellulose, Stearic Acid, Natural Identical Chicken Flavour, Talc, Magnesium Stearate, Colloidal Silicon Dioxide
 
CONTRAINDICATIONS:

Do not administer in case of hypersensitivity to the active substances or to any of the excipients.
The product is suitable for dogs over 6 weeks of age.
Do not administer to Collie dogs (and their half-breeds) and American Cocker Spaniels.

SIDE EFFECTS:

Common side effects in dogs are tremor, dilated pupils and body weight loss.

If you notice any side effects, even those not already included in this leaflet, or you think the medicine has had no effect, please inform your veterinarian.

DOSAGE FOR EACH SPECIES, ROUTE OF ADMINISTRATION AND METHOD OF ADMINISTRATION:

The product is administered orally in a dose of 1 tablet for animals with a body weight between 13 – 25 kg and 2 tablets for animals with a body weight between 26 – 50 kg.

For the treatment of larval heartworm disease (microfilariasis), the same dose is given one month after the first administration to prevent the development of larvae.

RECOMMENDATIONS ON CORRECT ADMINISTRATION:

To ensure the correct dose, the weight of the animals will be established as accurately as possible.

WAITING TIME:

This is not the case.

SPECIAL PRECAUTIONS FOR STORAGE:

Keep out of sight and reach of children.

Store below 25oC in the original packaging.

Protect from light and moisture.

SPECIAL WARNINGS:

Do not use in weak animals.

The following practices should be avoided as they increase the risk of developing resistance and ultimately lead to treatment ineffectiveness:

Frequent and repeated use of antiparasitics of the same class, over a long period of time;

Underdosing that can result from underestimating the body weight of animals.

Special precautions for use:

Special precautions for use in animals:

It does not exist.

Special precautions to be taken by the person administering the veterinary medicinal product to animals:

In case of accidental ingestion of the product or allergies caused by its contact with the skin, seek medical advice immediately and present the product leaflet or label.

People with known hypersensitivity to one of the components of the product should avoid contact with it.

Use during pregnancy, lactation or during the laying period:

There are no contraindications for administration to females during mating, gestation and lactation.

Interactions with other medicinal products or other forms of interaction:

They are not known.

Overdose (symptoms, emergency procedures, antidotes), as appropriate:

In case of overdose, symptoms of intolerance (lethargy, ataxia, tremor, mydriasis) may occur.